Lv1
40 积分 2022-05-31 加入
Cadonilimab for recurrent small cell neuroendocrine carcinoma of the cervix: a phase 2 study
5小时前
已完结
Phase 2 test of QBS72S for breast cancer leptomeningeal disease
28天前
已完结
Efficacy and safety of cadonilimab in previously treated recurrent or metastatic nasopharyngeal carcinoma(COMPASSION-06): A phase II multicenter study
1个月前
已完结
BL-B01D1, a first-in-class EGFR-HER3 bispecific antibody-drug conjugate, in patients with locally advanced or metastatic solid tumours: a first-in-human, open-label, multicentre, phase 1 study
1个月前
已完结
BL-B01D1, a first-in-class EGFR-HER3 bispecific antibody-drug conjugate, in patients with locally advanced or metastatic solid tumours: a first-in-human, open-label, multicentre, phase 1 study
1个月前
已完结
Cadonilimab for recurrent small cell neuroendocrine carcinoma of the cervix: a phase 2 study
2个月前
已完结
Neoadjuvant Chemotherapy with Dual Immune Checkpoint Inhibitors for Advanced-Stage Ovarian Cancer: Final Analysis of TRU-D Phase II Nonrandomized Clinical Trial
2个月前
已完结
Efficacy and Safety of Camrelizumab Plus Apatinib in Patients With Refractory Chordoma: A Phase II Clinical Trial
2个月前
已完结
Pembrolizumab in patients with rare and ultra-rare sarcomas (AcSé Pembrolizumab): analysis of a subgroup from a non-randomised, open-label, phase 2, basket trial
2个月前
已完结
颅底脊索瘤的临床研究进展
2个月前
已完结
皖公网安备34019202002308
